News Releases

Dec 12, 2013
OncoMed Pharmaceuticals CEO Testifies on behalf of BIO at Congressional Hearing on FDA Drug Development and Manufacturing Challenges (Source: BIO)
OncoMed Pharmaceuticals CEO Testifies on behalf of BIO at Congressional Hearing on FDA Drug Development and Manufacturing Challenges (Source: BIO)

OncoMed Pharmaceuticals, Inc. is a wholly-owned subsidiary of Mereo BioPharma Group plc.
Please visit our parent site www.mereobiopharma.com for our Pipeline, Partnering Opportunities and Investors information.